These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surgery for Dupuytren's contracture of the fingers. Rodrigues JN; Becker GW; Ball C; Zhang W; Giele H; Hobby J; Pratt AL; Davis T Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010143. PubMed ID: 26648251 [TBL] [Abstract][Full Text] [Related]
3. What do we know about managing Dupuytren's disease cost-effectively? Dritsaki M; Rivero-Arias O; Gray A; Ball C; Nanchahal J BMC Musculoskelet Disord; 2018 Jan; 19(1):34. PubMed ID: 29370792 [TBL] [Abstract][Full Text] [Related]
4. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. Ball C; Pratt AL; Nanchahal J BMC Musculoskelet Disord; 2013 Apr; 14():131. PubMed ID: 23575442 [TBL] [Abstract][Full Text] [Related]
5. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation. Brazzelli M; Cruickshank M; Tassie E; McNamee P; Robertson C; Elders A; Fraser C; Hernandez R; Lawrie D; Ramsay C Health Technol Assess; 2015 Oct; 19(90):1-202. PubMed ID: 26524616 [TBL] [Abstract][Full Text] [Related]
6. Radiotherapy in Dupuytren's disease: a systematic review of the evidence. Kadhum M; Smock E; Khan A; Fleming A J Hand Surg Eur Vol; 2017 Sep; 42(7):689-692. PubMed ID: 28490266 [TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population. Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340 [TBL] [Abstract][Full Text] [Related]
9. Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren's disease-a randomized controlled trial (DupuyShock). Knobloch K; Hellweg M; Sorg H; Nedelka T Lasers Med Sci; 2022 Feb; 37(1):323-333. PubMed ID: 33483776 [TBL] [Abstract][Full Text] [Related]
10. A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial. Harrison E; Tan W; Mills N; Karantana A; Sprange K; Duley L; Elliott D; Blazeby J; Hollingworth W; Montgomery AA; Davis T Trials; 2017 Aug; 18(1):392. PubMed ID: 28841903 [TBL] [Abstract][Full Text] [Related]
11. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target. Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165 [TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy in the early stage of Dupuytren's disease. The indications, technic and long-term results]. Keilholz L; Seegenschmiedt MH; Born AD; Sauer R Strahlenther Onkol; 1997 Jan; 173(1):27-35. PubMed ID: 9082583 [TBL] [Abstract][Full Text] [Related]
13. Dupuytren's Contracture: Incidence of Injury-Induced Cases and Specific Clinical Expression. Samulėnas G; Rimdeika R; Braziulis K; Fomkinas M; Paškevičius R Medicina (Kaunas); 2020 Jun; 56(7):. PubMed ID: 32629785 [No Abstract] [Full Text] [Related]
16. Treatment of Dupuytren's contracture: a systematic review. Soreide E; Murad MH; Denbeigh JM; Lewallen EA; Dudakovic A; Nordsletten L; van Wijnen AJ; Kakar S Bone Joint J; 2018 Sep; 100-B(9):1138-1145. PubMed ID: 30168768 [TBL] [Abstract][Full Text] [Related]
17. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture. Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391 [TBL] [Abstract][Full Text] [Related]
18. Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study. Witthaut J; Bushmakin AG; Gerber RA; Cappelleri JC; Le Graverand-Gastineau MP Clin Drug Investig; 2011 Nov; 31(11):791-8. PubMed ID: 21967070 [TBL] [Abstract][Full Text] [Related]
19. [Dupuytren's disease. State of the art and therapeutic perspectives]. Corrado A; Cantatore FP Reumatismo; 2007; 59(2):118-28. PubMed ID: 17603691 [TBL] [Abstract][Full Text] [Related]
20. The influence of Dupuytren's disease fingers contracture degree on surgical treatment outcome. Stepić N; Končar J; Rajović M Vojnosanit Pregl; 2017 Jan; 74(1):19-23. PubMed ID: 29350502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]